Price target increase to A2.83 October 14, 2021 news....do not advertise external links.au//companies/news/963165/kazia-therapeutics-paxalisib-program-data-garners-increased-target-share-price-of-a283-from-edison-963165.html?SNAPI
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint